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A natural predominant flavanone naringenin that extracted from citrus fruits 
(grapefruit, orange) and tomato skin, has a wide range of pharmacological activities, 
including anti-inflammatory, antioxidant and anticancer effects. It is reported that 
naringenin exerts cytotoxic and apoptotic effects in several cancer cell line in a dose 
dependent manner, and when used in cancer chemotherapy (1-3). The aim of the 
current study was the development of new derivatives with increased anticancer 
potency. Seven naringenin oxime derivatives, including four new derivatives, were 
synthesized. The structure of compounds was elucidated by NMR (1H, 13C) and HRMS 
assay. The cytotoxic and antioxidant effects of the synthetic compounds were 
investigated and compared to those elicited by naringenin. The antioxidant effects of 
the prepared compounds were demonstrated by means of ORAC and DPPH assays 
while antiproliferative properties were determined by MTT method against human 
cervical carcinoma (Hela, SiHa), breast carcinoma (MCF-7, MDA-MB-231) and leukemia 
(HL-60) cell lines. 
The naringenin tert-butyl oxime demonstrated higher antiproliferative 
activity than parent and other synthetic derivatives, its calculated IC50 values were 19.5 
and 23.5 µM against MCF-7 and Hela cell lines, respectively. This compound was also 
induced apoptosis in Hela cells through the activation of caspase-3, and significant 
increase in the hypodiploid (sub G1) population as evidenced by cell cycle analysis.  
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